Showing results (551-560 of 2,814) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|March 19, 2015
Interaction between exogenous insulin, endogenous insulin, and glucose in type 2 diabetes patientsJurgita Janukonyté, Tina Parkner, Niels Henrik Bruun, et al.
Diabetes Technology & Therapeutics|March 20, 2015
An Overview of Current Regulatory Requirements for Approval of Biosimilar InsulinsLutz Heinemann, Hootan Khatami, Ross McKinnon, et al.
Diabetes Technology & Therapeutics|August 1, 2012
An update in incretin-based therapy: a focus on glucagon-like peptide-1 receptor agonistsKrystal L Edwards, Megan Stapleton, Jessica Weis, et al.
Diabetes Technology & Therapeutics|August 1, 2012
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured populationJohn A Romley, Dana P Goldman, Matthew Solomon, et al.
Diabetes Technology & Therapeutics|September 15, 2012
Effect of metformin glycinate on glycated hemoglobin A1C concentration and insulin sensitivity in drug-naive adult patients with type 2 diabetes mellitusManuel González-Ortiz, Esperanza Martínez-Abundis, José A Robles-Cervantes, et al.
Diabetes Technology & Therapeutics|June 27, 2012
Effects of frequency of follow-up on quality of life of type 2 diabetes patients on oral hypoglycemicsMing Hu, Zhiguang Zhou, Fang Zeng, et al.
Diabetes Technology & Therapeutics|July 11, 2012
Human breath gas analysis in the screening of gestational diabetes mellitusSusanne Halbritter, Mattia Fedrigo, Vera Höllriegl, et al.
Diabetes Technology & Therapeutics|July 11, 2012
Association of His1085His INSR gene polymorphism with type 2 diabetes in South IndiansDhanasekaran Bodhini, Mohanram Sandhiya, Saurabh Ghosh, et al.
Diabetes Technology & Therapeutics|July 11, 2012
Evaluation of a new reusable insulin pen (ClikSTAR) in Canadian patients with type 1 and type 2 diabetes mellitus receiving insulin glargineIrving Gottesman, Patrice Perron, Lori Berard, et al.
Diabetes Technology & Therapeutics|July 11, 2012
A crossover comparison of glycemic variations in Japanese patients with type 1 diabetes receiving insulin glargine versus insulin detemir twice daily using continuous glucose monitoring (CGM): J COLLECTION (Jikei COmparison of Lantus and LEvemir with Cgm for Thinking Insulin OptimizatioN)Daisuke Tsujino, Rimei Nishimura, Aya Morimoto, et al.
Pageof 282